News

The CDC has updated interim guidance for healthcare providers who are caring for pregnant women with potential exposure to Zika virus.

Introducing HIV screening in primary care offices has the potential to save lives and decrease the costs associated with treatment by increasing rates of early diagnosis.

Researchers from Washington University, in St. Louis, find correlations between specific groups of intestinal viruses and the risk of type 1 diabetes.

In a recent editorial, Matthew Barnhart MD, MPH, medical officer for the US Agency for International Development (USAID) explored 5 new HIV drugs that are in the pipeline.

Contagion® covered the 9th International AIDS Conference on HIV Science this week and much of the research presented at the conference made this week’s Top 5. Topics include: the successful use of oral Truvada in adolescents, a new long-acting two-drug injectable HIV regimen, and a closer look at humanized monoclonal antibody PRO 140 for HIV treatment. Additional Top 5 articles include coverage from the Biodefense World Summit, and lack of infant immunizations across the world.

Differences in the clinical presentations of ZIKV infection which are occurring in different parts of the world might be an obstacle to setting a case definition that is good for use in all areas.

With summer in full swing, the Centers for Disease Control and Prevention offers tips to prevent catching recreational water illnesses from pathogens such as Cryptosporidium, Escherichia coli, Giardia, Shigella, and norovirus.

Data gleaned from a new study suggests that drug-resistant “superbugs” are not necessarily out-competing other strains.

As the case count grows in a multistate Salmonella outbreak, health officials work to pinpoint the exact point of contamination in the Maradol papayas supply chain.

Nader Pourhassan, PHD, president and chief executive officer of CytoDyn, the biotechnology company that acquired PRO 140, offers insight into the antibody as treatment for HIV.

Due to concerns that the use of PrEP might hinder clinicians from detecting HIV in infected individuals or lead to the development of resistant strains of HIV, scientists studied how PrEP affects seroconversion after HIV is acquired.

A phase 2a clinical trial has found the dapivirine vaginal ring to be a safe and acceptable means for HIV prevention in adolescents, who showed notably high adherence when using the ring.

Recent research coming in from Weill Cornell Medicine/Memorial Sloan Kettering suggests that a possible cure for Zika virus may be hiding in plain sight.

The NIH has released the findings of the first of 2 early-stage clinical trials on assessing the safety and effectiveness of HIV candidate vaccinations that support additional development of vaccines.

As the IAS Conference on HIV Science wraps up this week, this Public Health Watch report takes a closer look at the challenges that remain when it comes to treating HIV.

Phase 2 study finds that the use of daily oral Truvada as a means of HIV prevention is safe and acceptable.

Scientists make an interesting connection between bats and detecting undiscovered disease.

In a time of growing population and dependence on food, what methods are the best to use for food safety detection?

Researchers reported at the 9th IAS Conference on HIV Science that a HIV-infected child who had been treated in infancy has maintained remission without drugs since 2008.

A recent study finds that the majority of HIV-infected transgender women are anxious about taking ART and feminizing hormone therapy simultaneously due to hazardous drug interactions.

Universal health coverage comes at a price but can countries afford it?

WHO and IAS come together to create the first-ever global research prioritization agendas at the 9th IAS Conference on HIV Science in Paris, France.

Study finds that hepatitis C patients who had reached sustained virologic response using direct-acting antiviral drugs show a considerably reduced risk of the most common type of liver cancer.

A recent WHO news release reports that infant immunization rates continue to fall short of the global immunization target of 90%.

The results of a phase 2 trial for a 2-drug regimen of long-acting cabotegravir and rilpivirine and a 3-drug regimen in patient with HIV showed comparable viral suppression rates at 96 weeks.

Researchers from Dartmouth College’s Geisel School of Medicine have found that pregnant women with a history of HSV-1 maintain active antibodies against the virus that can be passed on to their newborns.

A team of researchers assesses the impact of “Rory’s Regulations,” a set of mandates for hospitals in New York State that establish protocols for the diagnosis and treatment of sepsis.

The World Health Organization (WHO) recently sent out a global alert warning of the growing threat of resistance to HIV drugs.

A systematic review analyzes the opportunity to provide coordinated care for HIV and noncommunicable conditions.